Speaker Biographies for Briefing on CDC Report, ''Antibiotic Resistance Threats to the United States, 2013''

Thomas Frieden, M.D., M.P.H.
Director, U.S. Centers for Disease Control and Prevention

Tom Frieden, M.D., M.P.H., became director of the Centers for Disease Control and Prevention in June 2009. Dr. Frieden has worked to control health threats from infectious diseases, respond to emergencies, and battle the leading causes of suffering and death in our nation and around the world. As the director of our nation's health protection agency, he is leading CDC to address these challenging health priorities.

A physician with training in internal medicine, infectious diseases, public health, and epidemiology, Dr. Frieden is especially known for his expertise in tuberculosis control. Dr. Frieden worked for CDC from 1990 until 2002. He began his career at CDC as an Epidemic Intelligence Service officer at the New York City Health Department.

Dr. Frieden graduated from Oberlin College. He received his medical degree and Master of Public Health degree from Columbia University and completed infectious disease training at Yale University. He has received many awards and honors and has published more than 200 scientific articles.

Victoria Nahum
Founder, Safe Care Campaign

Mother of Josh Nahum, who died from an antibiotic-resistant infection

Victoria Nahum is the face the American health care system has come to associate with the problem of health-care-acquired infections. In 2006, three members of her family became infected in three different hospitals in three different states in 10 months' time, culminating in the death of her stepson, Josh. He was 27.

Just weeks after Josh's death, she and her husband, Armando, created Safe Care Campaign (www.safecarecampaign.org) to bring a sharper focus on infection prevention within the American health care environment. Safe Care Campaign partners with health care systems, hospital administrations, and front-line caregivers to remind, provoke, motivate, and inspire all who work within the continuum of care of their most noble challenge and moral duty to prevent these infections, which annually infect more than 1.7 million people and kill more than 99,000 in the United States.

Victoria sits on the Joint Commission's Patient and Family Advisory Council, the board of directors of Consumers Advancing Patient Safety, and the Georgia Hospital Association Advisory Board to Prevent Infection. She is an associate of the World Health Organization's Patients for Patient Safety Programme.

David A. Relman, M.D., FIDSA
President, Infectious Diseases Society of America (IDSA)

David A. Relman, M.D., FIDSA, is the Thomas C. and Joan M. Merigan Professor in the Departments of Medicine and of Microbiology and Immunology at Stanford University. Dr. Relman also serves as chief of the infectious diseases section of the Veterans Affairs Palo Alto Health Care System.

He is the IDSA representative to the Institute of Medicine's Forum on Microbial Threats, as well as chair of the forum. Dr. Relman is a fellow of the American Academy of Microbiology and the American Association for Advancement of Science, and he is a member of the Association of American Physicians and the Institute of Medicine of the National Academies. He graduated from Harvard Medical School, completed his internship and residency at Massachusetts General Hospital, and went on to Stanford University, where he completed a clinical and research fellowship in infectious diseases.

Allan Coukell, B.Sc.Pharm.
Senior Director, Drugs and Medical Devices, The Pew Charitable Trusts

Allan Coukell oversees medical programs, including The Pew Charitable Trusts' prescription project, the drug safety project, the antibiotics and innovation project, the medical device initiative,  the innovate FDA project and other activities related to medical products and services.

Mr. Coukell practiced as a clinical pharmacist in oncology at the Victoria Hospital and London Regional Cancer Center in London, Ontario, and served subsequently as a senior medical writer and editor with Adis International, publisher of the peer-reviewed journals Drugs, Drugs & Aging, and PharmacoEconomics, among others. He also spent a decade in journalism and received an Edward R. Murrow Award for hard news reporting.

Mr. Coukell serves as the consumer representative on the FDA Cardiovascular and Renal Drugs Advisory Committee. He received a Bachelor of Science degree in pharmacy from the University of Manitoba, Canada.